$NORD
Nordicus Partners Corp

2024 Q2 Form 10-Q Financial Statement

#000149315224033179 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q2
Revenue $2.500K $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $258.2K $86.63K $51.59K
YoY Change 400.43% -96.59%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.400K
YoY Change
% of Gross Profit
Operating Expenses $258.2K $86.63K $51.59K
YoY Change 400.43% -96.59% -98.98%
Operating Profit -$258.2K -$51.59K
YoY Change 400.43% -98.98%
Interest Expense $0.00 $0.00 $1.910K
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $0.00 $11.29K
YoY Change -100.0%
Pretax Income -$258.2K -$84.13K -$40.30K
YoY Change 540.68% -96.69% -99.2%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$258.2K -$84.13K -$40.30K
YoY Change 540.68% -96.69% -99.2%
Net Earnings / Revenue -3365.2%
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share -$0.01 -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 31.31M shares 11.03M shares 8.571M shares
Diluted Shares Outstanding 31.31M shares 8.571M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.73K $49.93K $32.04K
YoY Change -16.57% 598.32% -82.77%
Cash & Equivalents $26.73K $49.93K $32.04K
Short-Term Investments
Other Short-Term Assets $53.63K $0.00 $780.00
YoY Change 6775.64% -100.0% -61.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $80.35K $49.93K $32.82K
YoY Change 144.87% -4.71% -82.55%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill $18.64M
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments $1.750M $1.750M $1.750M
YoY Change 0.0%
Other Assets $317.5K $7.640K $2.639K
YoY Change 11931.49% 191.05%
Total Long-Term Assets $20.72M $1.758M $1.753M
YoY Change 1082.24% 66857.71%
TOTAL ASSETS
Total Short-Term Assets $80.35K $49.93K $32.82K
Total Long-Term Assets $20.72M $1.758M $1.753M
Total Assets $20.80M $1.808M $1.785M
YoY Change 1065.01% 3185.0% 849.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $65.16K $5.020K $9.260K
YoY Change 603.67% -62.76% 32.29%
Accrued Expenses
YoY Change
Deferred Revenue $7.500K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $65.16K $26.41K $23.15K
YoY Change 181.41% -3.52% 28.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $65.16K $26.41K $23.15K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $65.16K $26.41K $23.15K
YoY Change 181.41% -3.52% 28.63%
SHAREHOLDERS EQUITY
Retained Earnings -$44.14M -$43.88M -$42.24M
YoY Change 4.51% 4.0% 8.97%
Common Stock $49.46K $11.10K $10.80K
YoY Change 358.15% 33.82% 79.93%
Preferred Stock
YoY Change
Treasury Stock (at cost) $30.33K $30.33K $30.33K
YoY Change 0.0% 0.0% 1.09%
Treasury Stock Shares
Shareholders Equity $19.79M $1.781M $1.762M
YoY Change
Total Liabilities & Shareholders Equity $20.80M $1.808M $1.785M
YoY Change 1065.01% 3185.0% 849.71%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q2
OPERATING ACTIVITIES
Net Income -$258.2K -$84.13K -$40.30K
YoY Change 540.68% -96.69% -99.2%
Depreciation, Depletion And Amortization $1.400K
YoY Change
Cash From Operating Activities -$217.5K -$107.9K -$48.00
YoY Change 453127.08% -52.73% -99.92%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $134.6K
YoY Change
Cash From Investing Activities $134.6K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $60.00K 114.4K $25.00K
YoY Change 140.0% -50.25%
NET CHANGE
Cash From Operating Activities -$217.5K -107.9K -$48.00
Cash From Investing Activities $134.6K
Cash From Financing Activities $60.00K 114.4K $25.00K
Net Change In Cash -$22.98K 6.440K $24.95K
YoY Change -192.08% 318.18% -141.59%
FREE CASH FLOW
Cash From Operating Activities -$217.5K -$107.9K -$48.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q2 dei Entity File Number
EntityFileNumber
001-11737
CY2024Q2 dei Entity Registrant Name
EntityRegistrantName
NORDICUS PARTNERS CORPORATION
CY2024Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3186647
CY2024Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
280 South Beverly Dr.
CY2024Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 505
CY2024Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Beverly Hills
CY2024Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2024Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90212
CY2024Q2 dei City Area Code
CityAreaCode
310
CY2024Q2 dei Local Phone Number
LocalPhoneNumber
666-0750
CY2024Q2 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
usd
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
usd
CY2024Q1 us-gaap Goodwill
Goodwill
usd
CY2024Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
usd
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q1 us-gaap Minority Interest
MinorityInterest
usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2023Q2 NORD Consulting Expense
ConsultingExpense
usd
CY2024Q2 us-gaap Investment Income Net
InvestmentIncomeNet
usd
CY2024Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
usd
CY2024Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
usd
CY2023Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
usd
CY2023Q2 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
usd
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2024Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q2 us-gaap Stock Issued1
StockIssued1
usd
CY2024Q2 dei Document Type
DocumentType
10-Q
CY2024Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q2 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2024Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2024Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49622248 shares
CY2024Q1 us-gaap Cash
Cash
49933 usd
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
53627 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
49933 usd
CY2024Q1 NORD Noncurrent Asset Website
NoncurrentAssetWebsite
7640 usd
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
317511 usd
CY2024Q2 us-gaap Goodwill
Goodwill
18641985 usd
CY2024Q2 us-gaap Long Term Investments
LongTermInvestments
1750000 usd
CY2024Q1 us-gaap Long Term Investments
LongTermInvestments
1750000 usd
CY2024Q2 us-gaap Assets
Assets
20800789 usd
CY2024Q1 us-gaap Assets
Assets
1807573 usd
CY2024Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
65155 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5019 usd
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7500 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
65155 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
26405 usd
CY2024Q2 us-gaap Liabilities
Liabilities
65155 usd
CY2024Q1 us-gaap Liabilities
Liabilities
26405 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
49465276 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11102248 shares
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
49462 usd
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
11102 usd
CY2024Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1534 shares
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1534 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
30328 usd
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
30328 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63911274 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
45686769 usd
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3078 usd
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2848 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44141696 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-43883527 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
19785634 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1781168 usd
CY2024Q2 us-gaap Minority Interest
MinorityInterest
950000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20735634 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1781168 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20800789 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1807573 usd
CY2024Q2 us-gaap Officers Compensation
OfficersCompensation
49442 usd
CY2023Q2 us-gaap Officers Compensation
OfficersCompensation
27000 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
25782 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
19925 usd
CY2024Q2 NORD Consulting Expense
ConsultingExpense
150000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4664 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
258169 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
51589 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-258169 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-51589 usd
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
1913 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
9380 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
11293 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-258169 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40296 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-258169 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-40296 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-230 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-61 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-258399 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40357 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31305435 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31305435 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8570973 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8570973 shares
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1781168 usd
CY2024Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
18050000 usd
CY2024Q2 NORD Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
60000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
138979 usd
CY2024Q2 NORD Adjustments To Additional Paid In Forgiveness Of Debt Related Party
AdjustmentsToAdditionalPaidInForgivenessOfDebtRelatedParty
13886 usd
CY2024Q2 NORD Stock Issued During Period Recognition Of Noncontrolling Interest
StockIssuedDuringPeriodRecognitionOfNoncontrollingInterest
950000 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-258399 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
20735634 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27658 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
27658 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1750000 usd
CY2023Q2 NORD Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
25000 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-40357 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1762301 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1762301 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-258169 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-40296 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
138979 usd
CY2024Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
1402 usd
CY2024Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
122618 usd
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
19 usd
CY2023Q2 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-44481 usd
CY2024Q2 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-7500 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-4954 usd
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
30357 usd
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
740 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-217549 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-48 usd
CY2024Q2 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
134572 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
134572 usd
CY2024Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
60000 usd
CY2023Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
25000 usd
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
60000 usd
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-22977 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
24952 usd
CY2024Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-230 usd
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-61 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
49933 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7149 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26726 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32040 usd
CY2023Q2 us-gaap Stock Issued1
StockIssued1
1750000 usd
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zLIqXRgLex52" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_zEFp5gR8djyg">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The Company’s accounting estimates include the collectability of receivables, useful lives of long-lived assets and recoverability of those assets, impairment in fair value of goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zOioqSnK90x8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zAt5QDnMvcMf">Concentration of Credit Risk</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6269000 shares
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
6610000 shares
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-44141696 usd
CY2024Q2 NORD Adjustments To Additional Paid In Forgiveness Of Debt Related Party
AdjustmentsToAdditionalPaidInForgivenessOfDebtRelatedParty
13886 usd
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q2 NORD Preferred Stock Issued And Redeemed Shares
PreferredStockIssuedAndRedeemedShares
500000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares

Files In Submission

Name View Source Status
0001493152-24-033179-index-headers.html Edgar Link pending
0001493152-24-033179-index.html Edgar Link pending
0001493152-24-033179.txt Edgar Link pending
0001493152-24-033179-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
nord-20240630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nord-20240630_cal.xml Edgar Link unprocessable
nord-20240630_def.xml Edgar Link unprocessable
nord-20240630_lab.xml Edgar Link unprocessable
nord-20240630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed